The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
about
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.Endocannabinoids in synaptic plasticity and neuroprotection.Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain.PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisMonoacylglycerol lipase is a therapeutic target for Alzheimer's diseaseActivation of cannabinoid receptor 2 inhibits experimental cystitisProgesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion.Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury.Remote neurodegeneration: multiple actors for one play.Endocannabinoids and Heterogeneity of Glial Cells in Brain Function.Endocannabinoid 2-arachidonylglycerol protects primary cultured neurons against homocysteine-induced impairments in rat caudate nucleus through CB1 receptor.The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis.The Endocannabinoid System and Oligodendrocytes in Health and Disease
P2860
Q30661637-04922C2E-8919-40F4-9A94-64B9A5D01176Q34084682-E9F21F5E-F5F8-433A-BB7A-098FEF4F591FQ34451684-2A38455A-935D-4A98-8D33-22FD542E2F34Q34477695-5AFC3DC4-4AA8-4D2B-B32E-F33BA9F7855BQ35655078-5A048146-D1DF-491A-BA37-C36A8F705618Q36016406-902A9F13-05BB-4143-BDE9-5C063B945EC7Q36442881-5711D406-347C-460D-A3E6-63A7AC334B4CQ36838206-1315BA1D-2C77-483E-A61C-2BA6E3398700Q37718924-B0473039-4EFC-420B-A98F-372A68D28349Q38009737-4A3F4FA0-659E-469B-8848-69D12FED2B34Q38179991-BE3236A9-13A9-443A-BC51-069977A66025Q41831886-7D54C4C2-C378-4C36-A969-8AC3DA5DBAB6Q42461874-9E42C801-E0BB-4CA8-AB56-32787DB44DB9Q48097673-FACBE592-884A-4891-A1B6-97EB54D1D2EAQ58707257-76BCCB12-7ACA-4839-9307-444239A944F2
P2860
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@en
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@nl
type
label
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@en
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@nl
prefLabel
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@en
The endocannabinoid 2-arachido ...... mage after spinal cord injury.
@nl
P2093
P50
P1476
The endocannabinoid 2-arachido ...... amage after spinal cord injury
@en
P2093
Angel Arevalo-Martin
Daniel Garcia-Ovejero
Eduardo Molina-Holgado
P304
P356
10.1016/J.NBD.2010.02.002
P577
2010-02-13T00:00:00Z